Class Action Investigation Focuses on Mission-Calavo Merger Prior to April 28 Shareholder Vote—Is There a Potential Opportunity for Mispricing?

Focused Legal Investigation Targets Key M&A Deals

Currently, a specialized legal inquiry is underway, led by class action attorney Juan Monteverde's firm—recently named a Top 50 M&A class action firm in the 2025 ISS report. The firm is examining four particular transactions, not issuing a broad market alert but rather zeroing in on deals where shareholder votes are imminent.

For investors, the central issue is whether this investigation will temporarily distort valuations or if it points to more significant obstacles that could derail the deals. No lawsuits have been filed yet; the investigation itself is the catalyst, publicly questioning the fairness of these transactions. Of the four deals under review, two are scheduled for shareholder votes next month, setting a clear timeline for potential market impact.

Deals Under Review

• Kennedy-Wilson Sale: Shareholders are offered $10.90 in cash per share.
• Mission-Calavo Merger: Calavo shareholders stand to receive $14.85 in cash and 0.979 shares of Mission Produce stock. The shareholder vote for this deal is set for April 28, 2026.

These events create a defined window for market reaction as the votes approach.

At this stage, the investigation injects uncertainty, prompting investors to reassess the fairness of the deals just before crucial votes. The outcome depends on whether the probe escalates into legal action that could delay or alter the deals, or if it simply fades as voting proceeds.

Deal Structures and Valuation Implications

While the investigation centers on procedural fairness rather than pricing, the terms of each deal play a critical role in shaping investor strategy. The immediate impact on valuation depends on the size of the premium and the complexity of the deal structure, which can create friction for shareholders and opportunities for legal leverage.

• Kennedy-Wilson: The $10.90 per share offer represents a 46% premium over the pre-announcement price, establishing a strong price floor. The timing of the investigation—right before the vote—will test whether this premium is enough to satisfy shareholders, especially if procedural concerns are raised.
• Mission-Calavo: This merger is more intricate, offering both cash and stock. The cash portion is straightforward, but the value of the stock component depends on Mission Produce’s future performance, introducing uncertainty. Such complexity is often targeted in class actions, as it can obscure the true value and raise questions about disclosure.

Another deal under scrutiny is the all-cash acquisition of Skywater Technology, where shareholders are offered $15.00 per share. Although this structure is simpler, the investigation will focus on how the price was negotiated and approved, regardless of the premium’s size.

Strategy Backtest: Absolute Momentum Long-only

Strategy Overview: Go long on KWC when the 252-day rate of change is positive and the closing price is above the 200-day simple moving average (SMA). Exit positions if the close drops below the 200-day SMA, after 20 trading days, or if a take-profit (+8%) or stop-loss (−4%) is triggered. The backtest covers the past two years.

• Entry Condition: 252-day rate of change > 0 and close > 200-day SMA
• Exit Condition: Close < 200-day SMA, or after 20 trading days, or take-profit (+8%), or stop-loss (−4%)
• Asset: KWC
• Risk Controls: Take-Profit: 8%, Stop-Loss: 4%, Maximum Hold: 20 days

Backtest Results:

• Strategy Return: 0%
• Annualized Return: 0%
• Max Drawdown: 0%
• Win Rate: 0%
• Total Trades: 0
• Winning Trades: 0
• Losing Trades: 0
• Average Hold Days: 0
• Max Consecutive Losses: 0
• Profit/Loss Ratio: 0
• Average Win Return: 0%
• Average Loss Return: 0%
• Max Single Return: 0%
• Max Single Loss Return: 0%

Assessing Risk and Opportunity

This investigation creates a distinct risk/reward scenario. The immediate risk is that if procedural flaws are found, deals could be renegotiated or delayed, potentially reducing the payout to shareholders. For example, even with Kennedy-Wilson’s 46% premium, the outcome depends on the investigation’s findings. Similarly, the complexity of the Mission-Calavo merger could open the door for legal challenges, possibly resulting in concessions that diminish shareholder value.

The tactical opportunity lies in the gap between the current trading price and the deal price. If the investigation gains momentum, this gap may narrow as uncertainty rises, with the market pricing in a greater chance of delay or a lower final settlement. This creates a window where the stock trades near the deal price, but the risk of a less favorable outcome increases. Investors must balance this risk against the possibility that the investigation does not result in any material changes, preserving the premium.

Success in this environment depends on monitoring for clear signals. The investigation is not yet a lawsuit. Its significance will become apparent if a formal complaint is filed or settlement talks begin. Monteverde & Associates’ reputation as a Top 50 M&A class action firm adds weight to their actions. Any move toward litigation or settlement would directly impact the deals, forcing acquirers to defend or improve their offers. Until then, the risk/reward balance hinges on ongoing scrutiny of the process.

Key Catalysts and Monitoring Points

The investigation itself is a catalyst, but the market will only react to concrete developments. The most immediate event to watch is the Mission-Calavo shareholder vote on April 28, 2026. Any procedural issues raised by the investigation must be addressed before this vote to avoid rejection or delay.

Another critical indicator is any formal action by the M&A Class Action Firm. The threat becomes real if a lawsuit is filed or a settlement is announced. Given the firm’s strong track record, such moves would carry significant weight, potentially forcing acquirers to renegotiate terms or postpone votes.

Finally, keep an eye on how the target stocks trade relative to the deal prices. The market continuously reassesses risk. If the investigation gains traction, share prices may dip below the announced offer, shrinking the premium. For instance, Kennedy-Wilson’s $10.90 per share offer—a 46% premium—could come under pressure if the market senses the premium is at risk. Watch for changes in this price gap as the April 28 vote approaches.